The role of recombinant lysine-plasminogen and recombinant urokinase and sulfur hexafluoride combination in inducing posterior vitreous detachment.
Gandorfer
Arnd
A
Kampik
Anselm
A
D000818:Animals; D004338:Drug Combinations; D005341:Fibrinolysin / Q000096:biosynthesis; D010446:Peptide Fragments / Q000008:administration & dosage*; D010958:Plasminogen / Q000008:administration & dosage*; D011817:Rabbits; D011994:Recombinant Proteins / Q000008:administration & dosage; D013459:Sulfur Hexafluoride / Q000008:administration & dosage*; D014568:Urokinase-Type Plasminogen Activator / Q000008:administration & dosage*; D014822:Vitreous Body / Q000378:metabolism*; D020255:Vitreous Detachment / Q000139:chemically induced*
D004338:Drug Combinations; D010446:Peptide Fragments; D011994:Recombinant Proteins; C018998:lysyl-plasminogen; D010958:Plasminogen; D005341:Fibrinolysin; D014568:Urokinase-Type Plasminogen Activator; D013459:Sulfur Hexafluoride